> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Quietly ‘Retires’ Autism Bogus Therapies Page
- URL: https://www.fdaweb.com/fda-quietly-retires-autism-bogus-therapies-page/
- Published: 2026-01-14T12:00:00.000Z
- Updated: 2026-09-14T15:30:37.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5160492

At the end of 2025, FDA removed from its Web site an informational page warning parents about the dangers of bogus autism treatments. An online *Ars Technica* [post](https://arstechnica.com/health/2026/01/warning-about-bogus-autism-treatments-vanishes-from-fdas-website/?ref=fdaweb.com) says elimination of the page was confirmed by HHS, which said it had been retired as part of a routine cleanup of old Web pages.

The post says the Web page, “Be Aware of Potentially Dangerous Products and Therapies that Claim to Treat Autism,” gave a short description of autism followed by a list of evidence-based FDA approved medications that can help manage its symptoms. It also listed some false claims and unproven, potentially dangerous treatments the agency had been working to combat. “Some of these so-called therapies carry significant health risks,” FDA said on the page.

HHS referred *Ars Technica* to another Web page on healthcare fraud. It says that page’s section on autism has no links and simply says, “Unproven drug products for sale that claim to cure or treat autism are misleading and deceptive. They can lead to serious health problems while offering false hope for a condition that currently has no cure.”